Viewing Study NCT00188877



Ignite Creation Date: 2024-05-05 @ 11:56 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00188877
Status: COMPLETED
Last Update Posted: 2019-12-02
First Post: 2005-09-12

Brief Title: Intensity Modulated Radiation Therapy for Head and Neck Cancer
Sponsor: University Health Network Toronto
Organization: University Health Network Toronto

Study Overview

Official Title: A Phase II Study of Intensity Modulated Radiation Therapy for Nasopharyngeal Cancer
Status: COMPLETED
Status Verified Date: 2019-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Many normal tissues including the eyes brain and spinal cord are very close to cancers in the nasopharynx The dose of radiation delivered to the cancer is limited by tolerance of these normal tissues Standard radiation treatment techniques using three or four radiation beams cannot avoid delivering some dose of radiation to these normal tissues that do not need to get radiation Intensity Modulated Radiation Therapy IMRT uses many hundreds of computer-controlled radiation beams aimed at your cancer to try to lower the amount of radiation that normal tissues receive while still delivering the desired amount of radiation to your cancer and to areas that your doctor thinks may have cancer cells

The doctors at Princess Margaret Hospital are conducting this study in order to test whether the use of IMRT techniques can improve the chance of controlling your cancer in the head and neck region
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None